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Introduction
Crohn's disease (CD) is a chronic nonspecific inflammatory bowel disease 66 (IBD), which may affect any region of the gastrointestinal tract 67 intermittently with the terminal ileum and colon being the most 68 common [1] . The incidence and prevalence of CD were highest in 69 developed countries, with the highest annual incidence in North America 70 (20.2 per 100,000) and Europe (12.7 per 100,000). Similarly, the highest 71 worldwide prevalence of CD was found in Europe (322 per 100,000) and 72 North America (319 per 100,000) [2] . Furthermore, the incidence of CD 73 in the developing countries continues to increase. Regarding sexual 74 distribution, there was no sex preponderance in adult CD [1] . About 12% 75 of CD patients have a family history of IBD, with an even higher 76 proportion of family cases in younger individuals [3] . Although the exact 77 etiology of CD remains uncertain to date, there is evidence that it 78 involves a complex interaction between the individual's genetic 79 susceptibility, external environment, intestinal microbial flora and the 80 immune responses [4, 5] . Previous genome-wide association studies 81 have reported numerous loci associated with CD, which included NOD2, 82 ATG16L1 and IRGM. NOD2 was identified as the first susceptibility gene 83 for CD [6] . NOD2, a cytosolic pattern recognition receptor for the 84 bacterial proteoglycan fragment muramyl dipeptide, plays a significant 85 role in maintaining immunological homeostasis in the intestine. NOD2 5 86 mutations are genetically correlated with an increased risk for the 87 development of CD [5, 7] . Moreover, genetic analyses have identified 88 autophagy genes ATG16L1 and IRGM genes as susceptibility genes for 89 CD [8] . Together, these common susceptibility genes account for 13.1% 90 of variance in disease liability in CD [9] . 91 A large amount of gene expression datasets are currently freely 92 available from the Gene Expression Omnibus (GEO) database. Due to the 93 small sample sizes in a single dataset and discrepancies of the 94 characteristics within multiple heterogeneous datasets, it is necessary to 95 integrate those massive datasets through systems biology tools and 96 finally receive the stable and credible results [10] . So far, comprehensive 97 integrated analysis of gene expression datasets in CD is still missing. 98 Therefore, we executed integrated analysis method by using robust rank 99 aggregation (RRA) method to detect the consistently significant 100 differentially expressed genes (DEGs) from various expression profiling 101 datasets [11] . In addition, we performed weighted gene co-expression 102 network analysis (WGCNA) to categorise those DEGs into a number of 103 functional modules, and followed by functional and pathway enrichment 104 analysis [12] . Connectivity Map (CMap) represents a useful bioinformatic 105 technique for establishing the connections among genes, drugs and 106 diseases [13, 14] . CMap has been applied to discover drug action 107 mechanisms and disease pathogenesis, as well as to assist in the 6 108 identification of novel potential therapeutics [15, 16] . The DEGs of CD 109 and control intestinal tissues were used to query the CMap database, 110 which includes more than 7000 expression profiles corresponding to 111 1309 drugs. In the current study, we used CMap to explore therapeutic 112 drugs that could potentially be effective against CD. 113 Here, we screened the differentially expressed genes from the 114 intestinal tissue microarray data of CD patients and healthy people by 115 means of bioinformatics technology, and obtained the signal pathways 116 related to the disease through enrichment analysis. Moreover, the 117 potential therapeutic drugs for CD were explored via the CMap database. 118 The study will help to understand the pathogenesis of CD and lay a 119 theoretical foundation for molecular diagnosis and targeted therapy. Data preprocessing steps and statistical analysis were performed using R 142 software(https://www.r-project.org/) and Bioconductor packages [17] . 143 Microarray datasets were normalized using RMA [18]and differential 144 expression analysis was implemented using the limma R package [19] . 145 The statistical operations were performed using the Robust Rank Aggreg By using a RRA method to integrate 9 datasets, upregulated and 208 downregulated ranked gene lists were obtained. S1 Table showed those Small drug molecule screening 224 The related small molecules with highly significant correlations were 225 listed in Table 2 . Among these molecules, tetracycline showed minimum 226 p value and higher negative correlation, indicating the potential 227 molecular signature that may counteract those of CD. gene set that was not assigned to any of the modules ( Fig 2B) . 240 Interactions of the 7 co-expression modules were analyzed ( Fig 2C) . The 241 genes in each module were listed in S2 Table. 242 determined. In this study, we integrated the gene expression data to 289 shed light on the pathological mechanism of CD. to the ability to inhibit MMPs expression and treat overgrowth of 329 bacteria in the small intestine, tetracycline may be prescribed to treat 330 CD. We might suppose that tetracycline could play certain roles to 331 combat CD; however, further investigation on a large population is 332 required to firmly establish the therapeutic effect in CD. 333 The WGCNA which is a kind of bioinformatics analysis method was 334 conducted to explore the molecular mechanisms of various disease [40, 335 41]. Several reports involved IBD had been studied by this method [42, 336 43]. In this study, 5666 CD associated genes generated from RRA analysis 337 were used in WGCNA and most of them were classified into 7 338 co-expression modules. Six of the modules have significant associations 339 with disease (Fig 3) , which can be enriched more refined in three cluster 340 (Fig 4) 
